Skip to content
Application 125477
- Type
- BLA
- Sponsor
- ELI LILLY AND CO
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CYRAMZA | RAMUCIRUMAB | INJECTABLE;INJECTION | 100MG/10ML | No | No |
| 002 | CYRAMZA | RAMUCIRUMAB | INJECTABLE;INJECTION | 500MG/50ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7669 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |
| 0002-7678 | CYRAMZA | ramucirumab | Eli Lilly and Company | BLA | Current |